Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
228 results about "Drug side effects" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
ActiveUS7461006B2Risk of adverse drug reactionIncreased and decreased chanceBiostatisticsComputer-assisted medical data acquisitionPatient characteristicsGenomic DNA
A method for assessing and analyzing one or more drugs, adverse effects and associated risks, and patient characteristics resulting from the use of at least drug of interest is disclosed. The method comprises the steps of selecting one or more cases for analysis, said cases describing the behavior between at least one drug of interest and a patient genotype; profiling statistically derived values from multiple cases related to the safety of the at least one drug, wherein at least one filter is employed for deriving said values; at least one data mining engine; and an output device for displaying the analytic results from the data mining engine. A system for performing the method is likewise disclosed.
Owner:DRUGLOGIC
Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent
A neuroprotective composition for protecting neuronal cells against oxidative stress and methods for using and preparing the same. More particularly, the neuroprotective composition of the invention comprises a therapeutically effective amount of ceruloplasmin or a functional derivative thereof. The neuroprotective composition is characterized in that it protects neuronal cells from reactive oxygen species such as .O2- and .OH. In a preferred embodiment, the neuroprotective composition further comprises an antioxidant consisting of catalase or of an amphiphilic physiological antioxidative solution comprising a mixture of pyruvate, antioxidant, and lipid(s) such as fatty acids. The neuroprotective composition could be used for the treatment of brain trauma, brain or cerebrovascular ischemia, neurodegenerative diseases, poisoning of neuronal cells, the diminution of drugs side effects and for preservation of neuronal grafts.
Owner:WARNER LAMBERT CO LLC
Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice
InactiveCN103990081AReduced responseEliminate side effectsDigestive systemPlant ingredientsSalvia miltiorrhizaRhizome
The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition and application thereof in preparation of a medicine for treating infant jaundice. The traditional Chinese medicine composition comprises the components of isatis root, oriental wormwood, lalang grass rhizome, lysimachia christinae hance, cape jasmine, polyporus umbellatus, salvia miltiorrhiza, dandelion, plantain herb, fructus forsythiae, radix bupleuri, curcuma aromatic, polygonum cuspidatum, felwort, selfheal and liquorice. The traditional Chinese medicine composition shows a good effect on treating or preventing infant jaundice, and is low in side effect, and obviously worthy of clinical popularization.
Owner:叶雨玲
Chinese medicinal composition for treating gout and preparation method thereof
ActiveCN103520497APromoting blood circulation and removing stasisGood synergySkeletal disorderPlant ingredientsLicorice rootsRhizome
The invention discloses a Chinese medicinal composition for treating gout and a preparation method thereof and belongs to the technical field of medicines. The Chinese medicinal composition is prepared from the following raw materials in parts by weight: 10-50 parts of edible tulip, 10-20 parts of notopterygium root, 5-20 parts of Chinese angelica, 5-15 parts of rhizoma smilacis glabrae, 5-10 parts of dried rehmannia, 5-15 parts of longhairy antenoron herb, 5-15 parts of honeysuckle, 1-10 parts of radix clematidis, 5-15 parts of medlar, 9-15 parts of the root of bidentate achyranthes, 9-15 parts of szechuan lovage rhizome, 5-15 parts of angelica root, 0.2-9 parts of kudzuvine root, 5.5-15 parts of white paeony root, 6-9 parts of glossy privet fruit and 10-15 parts of licorice root. The Chinese medicinal composition has the good treatment effect in treatment or prevention of gout, low side effects of the medicine and obvious clinical promotional value.
Owner:吴琼
Preparation method of disulfide bond functionalized fluorescent mesoporous silica nanoparticles and application thereof
InactiveCN108310388AUniform particle size dispersionFluorescent properties are stablePowder deliveryInorganic non-active ingredientsNanocarriersFluorescence
The invention discloses a preparation method of disulfide bond functionalized fluorescent mesoporous silica nanoparticles and application thereof and belongs to the technical field of medicines. The preparation method comprises the following steps: preparing mercapto-modified mesoporous silica nanoparticles; taking quinoline zinc and amino as modified groups, carrying out a room temperature reaction in a light-shielded manner, thereby obtaining the disulfide bond functionalized fluorescent mesoporous silica nanoparticles. The fluorescent mesoporous silica nanoparticles have the particle size of 80-150nm, are stable in fluorescent property and can serve as a nanocarrier material for delivering antitumor drugs. The drug loading capacity can be effectively improved, drug release can be controlled, and side effects of the drug are decreased, so that related cancers are effectively treated.
Owner:HUBEI UNIV OF TECH
Method for predicting drug-side effect relationship based on graph neural network
ActiveCN112216396AQuality improvementEasy data collectionMedical data miningDrug referencesSide effectData acquisition
The invention discloses a method for predicting a drug side effect relationship based on a graph neural network. The method is used for solving the problem of how to express nodes in the network by using a deep learning method and fully considering information of edges and nodes. The method comprises the following steps: collecting drug data for preprocessing, and establishing relationships between drugs and between side effects of the drugs; constructing a drug side effect heterogeneous network model; and using a graph neural network to carry out vectorization representation on nodes and multi-relation edges in the network. According to the method, a multi-relation network is constructed, and nodes in the network are represented by utilizing a neural network; and crawling is carried out through public data of different platforms, thus features of drugs are described more comprehensively, data acquisition is convenient and rapid, the data are preprocessed and then analyzed, the miningeffect is enhanced, the quality of the mining data is improved, a heterogeneous network model capable of representing multi-modal data is constructed, a graph neural network method is used, and pointand edge information is combined.
Owner:FUDAN UNIV
Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof
ActiveCN103977127AReduce total serum IgE levelsReduced total IgE levelsRespiratory disorderPlant ingredientsSterculia scaphigeraWolfiporia extensa
Owner:NANTONG FINC PHARMA CHEM
Penfluridol-containing oral preparation and application thereof
The invention relates to a penfluridol oral preparation with novel specifications. Each dosage unit contains 2.5 to 3 mg of penfluridol. When the medicament of the invention is used, the prior common method of taking 20 mg of the medicament is changed from once a week into once a day. The oral preparation is used for the maintenance treatment of schizophrenics after undergoing other psychotherapy and pharmacotherapy and having obviously relieved symptoms, prevents relapse, avoids the side effects of taking the medicament once a week, and is economical, effective and fewer in side effects than other maintaining medicaments.
Owner:苏春华
Neuroprotective composition and uses thereof
InactiveUS20040235947A1Stabilizes cellular membranePromote normalizationBiocideNervous disorderSide effectNeuro-degenerative disease
Owner:PAQUIN JOANNE +2
METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOF
InactiveUS20200009185A1Effectively death of cancer cellMinimize side effectsHeavy metal active ingredientsOrganic active ingredientsIntracellularUbiquitin ligase
The present invention relates to a method for maintaining the increased intracellular p53 level, induced by a platinum-based anticancer drug, and an application thereof and, more specifically, to a method for maintaining the increased intracellular p53 level in cells by administering a platinum-based anticancer drug and siRNA to ubiquitin ligase for p53 to a subject in need thereof in combination and sequentially, and a composition for promoting cancer cell apoptosis using the same.According to the method of the present invention, the increased intracellular p53 expression level can be maintained for a long period of time in spite of the treatment with a low-concentration platinum-based anticancer drug, thereby effectively inducing the apoptosis of cancer cells and minimizing the drug side effect caused by the administration of the platinum-based anticancer drug, and thus the present invention can be favorably used in the prevention of cancer or the development of cancer medicines.
Owner:ENHANCEDBIO INC
Traditional Chinese medicine composite for treating haemorrhoids and application thereof
InactiveCN104983896AFully functionalGood drug treatmentMammal material medical ingredientsCardiovascular disorderPagoda treeMyrrh
The invention belongs to the technical field of traditional Chinese medicine and relates to a traditional Chinese medicine composite for treating haemorrhoids and the application thereof. The traditional Chinese medicine composite is prepared with portulaca oleracea, myrrh, panax pseudoginseng, mastix, rheum officinale, musk, dandelion, lonicera japonica, fresh rehmannia roots, honeysuckle stems, radix sanguisorbae, golden cypress, fructus forsythiae, pagoda tree fruits and liquorice. The traditional Chinese medicine composite is reasonable in medicine composition, remarkable effects of relieving swelling and pains, promoting blood circulation, removing blood stasis and clearing away heat and toxic materials in treating the haemorrhoids are achieved, the therapeutic effect of the composite is obvious, the medicine side effect is little, and the significant clinic promotion value is achieved.
Owner:QINGDAO LANSHENGYANG PHARMA & BIOTECH CO LTD
Application of geniposide in alleviating side effects of glucocorticoid
InactiveCN110051677AInhibit catabolismInhibit necrosisOrganic active ingredientsSenses disorderSide effectGlucocorticoid
The invention belongs to the field of synthetic drugs, and relates to an application of geniposide in alleviating side effects of glucocorticoid, and an application of compounds represented by the formula I or pharmaceutically acceptable salts, esters, or prodrugs in preparation of drugs for alleviating side effects of glucocorticoid. The molecular action mechanism of the compounds in alleviatingthe side effects of glucocorticoid drugs has important clinical significance for developing new drugs.
Owner:GUANGDONG MEDICAL UNIV
Externally used preparations with functions of anti-inflammation, relieving itching and sterilization disinfection, and method for preparing the same
ActiveCN101152546AGood treatment effectQuick effectHydroxy compound active ingredientsAntisepticsAdrenal tissueSide effect
The invention relates to an external preparation on the skin, which has obvious effects of inflammation reduction, itching relief and sanitization; active The components contain: rhubarb, turmeric root tuber, sublimed sulfur, baical skullcap root, radix glycyrrhizae, borneol, menthol and adrenal cortex hormone; calculated as pharmacological raw materials, the weight proportion of the active components rhubarb, turmeric root tuber, sublimed sulfur, baical skullcap root, radix glycyrrhizae, borneol and menthol are: 1 to 99 portion of rhubarb, 1 to 80 portion of turmeric root tuber, 1 to 70 portion of sublimed sulfur, 1 to 20 portion of baical skullcap root, 0.1 to 18 portion of radix glycyrrhizae, 0.1 to 10 portion of borneol, 0.1 to 10 portion of menthol and 0.1 to 10 portion adrenal cortex hormone. After smeared on the illness, the preparation has strong and quick disinfectant effect, can clean and care the skin, with good safety, little adverse reaction and low recurrence rate. In particular, when the skin is injured and a chronic disease is led, the preparation can still be used repeatedly for a long time, with obvious effect, convenience in us, and without side effect of hormones medicine.
Owner:西藏海容唐果药业有限公司
Traditional Chinese medicinal composition for treating diabetic nephropathy combined hypertensive nephropathy and preparation method thereof
ActiveCN103690784AGood synergySymptoms improvedPowder deliveryMetabolism disorderRadix Astragali seu HedysariRadix Ophiopogonis
The invention belongs to the technical field of medicines, relates to a traditional Chinese medicinal composition and a preparation method of the composition, in particular to a traditional Chinese medicinal composition for treating diabetic nephropathy combined hypertensive nephropathy and a preparation method of the composition. The traditional Chinese medicinal composition aims to overcome the defects in the prior art that the chemotherapeutic drugs for treating the diabetic nephropathy combined hypertensive nephropathy is high in hepatotoxicity and poor in the curative effect. The traditional Chinese medicinal composition for treating diabetic nephropathy combined hypertensive nephropathy comprises the following components: 10-50 parts of herba epimedii, 10-20 parts of bark of eucommia, 5-20 parts of dried rehamnnia root, 5-15 parts of sealwort, 5-15 parts of the root of kudzu vine, 1-10 parts of ginseng, 5-15 parts of medlar, 9-15 parts of radix astragali, 9-15 parts of glossy privet fruit, 5-15 parts of platycodon grandiflorum, 1.5-9 parts of radix ophiopogonis, and 5.5-15 parts of pinellia ternate. The traditional Chinese medicinal composition can achieve a good curative effect for treating or preventing diabetic nephropathy combined hypertensive nephropathy, is low in side effect, and has an obvious clinical promotional value.
Owner:NANTONG FINC PHARMA CHEM
Method for preparing medicine targeted controlled-release nano eyedrop
InactiveCN101209241AProlong the action timeSustained constant releasePowder deliverySenses disorderHigh concentrationSide effect
The invention discloses a preparation method for drug targeting controlled release nano-particle eye drops, which pertains to the preparation methods of eye preparations. The invention firstly dissolves certain portions by weight of drug and biodegradable polymer in organic solvent so as to obtain solution A; additionally, certain portions by weight of cholesterol modified chitosan is dissolved in water, and solution B is obtained by stirring and rotating; the two are mixed and stirred till the organic solvent is fully volatilized; the drug-carrying polymer nanoparticles are obtained by centrifugal separation, water washing and drying; and then the eye drops are prepared by the general preparation method of the industry of eye drops. The eye drops which are prepared by the method of the invention can ensure the effective drug treatment concentration without the need of frequent and high-concentration drug delivery, can significantly prolong the eye surface acting time of the drug and release the drug continuously and constantly, the eye surface retention time of the drug-carrying particles of the eye drops can be up to six hours, the efficacy is improved and the side effects of the drug are reduced simultaneously.
Owner:天津医科大学眼科中心
Biological network link prediction method based on meta-path and bidirectional encoder
ActiveCN112308326ACapture dependenciesEnsure balanceSemantic analysisForecastingInformation repositoryDrug interaction
The invention belongs to the field of computer science, and discloses a biological network link prediction method based on a meta-path and a bidirectional encoder. The method comprises the following steps: constructing a multi-source heterogeneous drug information network, and simultaneously designing a plurality of semantic paths for sequence sampling to form a large-scale semantic information base; organically fusing a depth Transformer encoder and a mask language model (mask language model) to design a depth two-way encoding representation model, and effectively extracting a low-latitude representation vector of each node; and finally, carrying out biological link prediction on a disease protein association relationship, a protein-drug interaction relationship, a drug side effect association relationship and the like by utilizing an induction matrix complementation technology, so as to complete a drug research and development technical system from disease to target to drug to side effect.
Owner:HUNAN UNIV
Virus capping system polypeptide inhibitor for controlling coronavirus
InactiveCN102675429AImprove featuresBacteriaPeptide/protein ingredientsSide effectAgricultural science
The invention relates to a virus capping system polypeptide inhibitor for controlling coronavirus and a method for inhibiting the activity of the coronavirus capping system by utilizing the polypeptide inhibitor. The polypeptide inhibitor comprises the polypeptide with the following amino acid sequence: 1) an amino acid sequence shown in SEQ ID No.1, 2) a sequence which has equivalent functions, is derived from the sequence shown in SEQ ID No.1 and is obtained by replacing, adding and / or deleting one or more amino groups in the amino acid sequence shown in SEQ ID No.1, or 3) a truncated sequence of the sequence shown in SEQ ID No.1, wherein the truncated sequence at least comprises GGASCCLYCRCH. The inhibitor has extremely high specificity, overcomes the defect that the traditional virus capping system inhibitors have low specificity and simultaneously overcomes the defect that the present nonspecific treatment drugs have high side effects and are easy to cause sequelae as a guide drug for controlling coronavirus.
Owner:WUHAN UNIV
Preparation method of controlled-release aspirin powder
InactiveCN104188917ASolve the problem that the release speed is too fastAchieve long-acting sustained releasePowder deliveryOrganic active ingredientsAspirinSimulated body fluid
The invention discloses a preparation method of controlled-release aspirin powder. The preparation method of the controlled-release aspirin powder comprises the steps of preparing a hollow nanosilicon dioxide drug carrier, loading aspirin on the hollow nanosilicon dioxide drug carrier and carrying out secondary coating on the loaded aspirin. The prepared aspirin-loaded drug carrier is immersed in nanosilicon dioxide ethyl alcohol sol, and stirring or ultrasonic treatment is carried out for 0.5-1 hour, so that secondary coating is carried out on the loaded aspirin by virtue of nanosilicon dioxide particles, and the coating thickness is optimized to be 10-20nm; in simulated body fluid, the release rate of the loaded aspirin subjected to the secondary coating in 24 hours is 40-55%, and the release rate of the loaded aspirin subjected to the secondary coating in 48 hours is 70-90%. The preparation method of the controlled release aspirin powder has the advantages that the problem that the existing controlled release aspirin medicine is high in release rate is solved, long-acting controlled release and controlled release can be realized, medication is easy, and the drug side effect is reduced.
Owner:TIANJIN VOCATIONAL INST
Traditional Chinese medicine composition for treating infant jaundice and preparation method thereof
ActiveCN103705860ASignificant anti-inflammatorySignificant pain reliefDigestive systemPlant ingredientsForest yamTherapeutic effect
The invention belongs to the field of medicines, and particularly relates to a traditional Chinese medicine composition for treating infant jaundice and a preparation method thereof, aiming to overcome the defects in the prior art that the existing chemical therapeutic medicines for treating infant jaundice have large toxicity to the liver and have poor curative effect. The traditional Chinese medicine composition for preventing or treating infant jaundice comprises the following components: turmeric, oriental wormwood, mangnolia officinalis, common yam rhizome, cape jasmine, poria, radix pseudostellariae, ginseng, wolfberry, astragalus membranaceus, coptis chinensis, rhizoma alismatis, radix ophiopogonis, radix paeoniae alba, leonurus and liquorice. The traditional Chinese medicine composition has good effect on treating and preventing infant jaundice, has low side effects, and has remarkable clinical promotion value.
Owner:启东市清汉农副产品专业合作社
Application of hydrogen saturated saline
ActiveCN105079025AEasy to makeHigh injection concentrationInorganic active ingredientsCardiovascular disorderSide effectVulnerable plaque
The invention relates to application of hydrogen saturated saline in preparation of drugs for stabilizing atherosclerotic plaques. The application has the advantages that a novel use of the hydrogen saturated saline is provided, and besides a function of inhibiting formation of atherosclerotic plaques, other functions of the hydrogen saturated saline such as stabilizing the atherosclerotic plaques and enabling the atherosclerotic plaques to be rarely vulnerable are disclosed for the first time; the hydrogen saturated saline is simple to prepare, high in injection concentration, convenient to use, free of explosion risk, low in cost and free of side effects; animal experiment results show that the hydrogen saturated saline has great therapeutic advantages, the risk of patients with vulnerable plaques to suffer drug side effects is greatly decreased, and the medical cost is greatly lowered.
Owner:TAISHAN MEDICAL UNIV
Targeted vesicle drug prepared through erythrocyte
ActiveCN111110855AImprove securityAvoid potential risksOrganic active ingredientsPeptide/protein ingredientsGenes mutationTherapeutic effect
The invention discloses a targeted vesicle drug prepared through erythrocyte. The vesicle drug wraps one or more of contents of to-be-wrapped cells without containing genetic materials or drugs. The vesicle drug utilizing the erythrocyte to perform cell preparation can wrap the bioactive substances of required cells removing nucleic acid to perform delivery, so that risks such as gene recombination and gene mutation of users caused by the containing of the genetic materials in cellular vesicles can be avoided, and therefore, the vesicle drug is safer. The vesicle drug can perform targeted delivery, so that treatment effects can be enhanced; targeted modification can be performed on the cellular vesicles, so that the drug can accurately reach disease sites, therefore, treatment effects canbe enhanced, and side effects of drugs can be reduced. Thus, cellular vesicle targeting carriers and drugs with higher safety and better treatment effects can be produced on a large scale through a method.
Owner:深圳百纳心致生命科学有限公司
Application of panax japonicus polysaccharide, total saponins of panax japonicus and panax japonicus saponin V
ActiveCN104490965APoor lung functionLittle side effectsOrganic active ingredientsRespiratory disorderSide effectMedicine
The invention discloses an application of panax japonicus polysaccharide, total saponins of panax japonicus, panax japonicus saponin V and a composition of panax japonicus polysaccharide and total saponins of panax japonicus in preparation of medicines for preventing and treating chronic obstructive pulmonary disease. The medicine containing the components is less in side effect, is originated from a single plant, is simple in component, and is definite in curative effect for preventing and treating COPD.
Owner:SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES
Pure Chinese medicinal herb preparation for treating cancer pain and postoperative pain and preparation method thereof
InactiveCN102370953AImprove pain symptomsAbandon the disadvantages of slow onset and poor effectAnthropod material medical ingredientsAntipyreticTherapeutic effectAdvanced carcinoma
The invention relates to a medicament for treating cancer pain and postoperative pain and a preparation method thereof, in particular to a pure Chinese medicinal herb preparation for treating cancer pain and postoperative pain and a preparation method thereof, which are mainly used for solving the technical problems of large side effects, high prices and poor treatment effects on patients suffering from advanced cancer pain and postoperative pain existing in the conventional medicament for treating cancer pain and postoperative pain. According to the technical scheme, the medicament for treating cancer pain and postoperative pain consists of the following components in percentage by weight: 35-45 percent of pillbug, 10-15 percent of greater celandine herb, 10-15 percent of paniculate swallowwort root, 10-15 percent of white paeony root, 5-15 percent of turmeric, 1-5 percent of centipede and 5-15 percent of unprocessed liquoric root. A preparation process comprises the following steps of: preparing the components according to the percentage by weight; adding water for decocting twice, wherein water is added in an amount that the medicament surface is submerged; combining decocted filtrates obtained in the two times; concentrating to a concentrated solution of which the specific weight is 1.1.12-1:1.4; putting into a clean stainless steel drying disk; performing vacuum drying, and smashing; and screening with a screen of 80-100 meshes to obtain a particular internal dosage form.
Owner:荣汝成
Pill Organization Utilizing A Voice-Based Virtual Assistant
InactiveUS20200335193A1Accurate doseDrug and medicationsMicrophones signal combinationOver the counter drugsDispensing medications
A system, device and method to assist users with taking their prescription medications, vitamins, insulin (alert only) and over the counter drugs are disclosed herein. The present invention assists the user with (including but not limited to): organizing their pills, taking their medication on time, taking the proper dosage of medication, providing warnings to avoid multiple / duplicative dosages, provide reminders to the user to take their medication on time, or remind them if they forgot to take their medication, and provide information regarding side effects of the medication and alert the user to dangers / risks of taking conflicting medications. The device preferably dispenses medication automatically based on pre-defined scripts and algorithms.
Owner:INTELLIMED AI
Nano-carrier material and preparation method and application thereof to preparation of antitumor drugs
ActiveCN111686249AGood dispersionUniform particle sizePowder deliveryEnergy modified materialsBiocompatibilityCombined treatment
The invention discloses a nano-carrier material. The nano-carrier material comprises gold nano particles, a SiO2 layer wrapping the gold nano particles, and a DSPAMAM layer wrapping the SiO2 layer, and DSPAMAM is disulfide cross-linked PAMAM. The nano-carrier material is easy to prepare, preparation raw materials are easy to obtain, quantitative production is easy to realize, and the advantages ofAuNR, SiO2 and the DSPAMAM are integrated; the biocompatibility is good, and a CT imaging function and GSH responsiveness are realized; the drug and gene loading function is further realized; an anti-cancer drug, namely CUR and a functional gene (miRNA) can be efficiently co-delivered in treatment of prostatic carlcer; and RGD is used as a targeting polypeptide, the RGD polypeptide can promote enrichment of nano-materials in tumor cells, drug controlled release can be achieved, side effects of the drugs can be reduced, and efficient diagnosis and combined treatment of human prostate cancer can be further realized.
Owner:BEOGENE BIOTECH GUANGZHOU
Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof
InactiveCN103751757ATreatment advantagePromoting blood circulation and removing stasisPowder deliveryDispersion deliveryForsythiaPharmacology
The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating acute nephritis and a preparation method thereof. The traditional Chinese medicine composition for treating or preventing acute nephritis comprises the following components: 10-50 parts of fructus forsythia, 10-20 parts of gardenia jasminoides ellis, 5-20 parts of periostracum cicada, 5-15 parts of canscora melastomacea, 5-10 parts of paris polyphylla, 5-15 parts of lily, 5-15 parts of selfheal, 1-10 parts of rhizoma alismatis, 5-15 parts of medlar, 9-15 parts of fructus cnidii, 9-15 parts of ligusticum wallichii, 5-15 parts of radix angelicae, 0.2-9 parts of lalang grass rhizome, 5.5-15 parts of radix paeoniae alba, 6-9 parts of rhizoma zingiberis, and 10-15 parts of liquorice. The traditional Chinese medicine composition has excellent effect on the treatment or prevention of the acute nephritis, is low in drug side effects, and has remarkable clinical popularization value.
Owner:王雪雁
Diet intervention composite for preventing and curing recurrent oral ulceration
InactiveCN102960613APromote healingSolve spleen deficiencyDigestive systemFood preparationGut floraCytokine
The invention discloses a diet intervention composite for preventing and curing recurrent oral ulceration. The diet intervention composite is prepared from the following components in percentage by weight: 22.5-67.5 of Se-enriched brown rice guangdong navigation No.1, 22.5-67.5 of polished rice guangdong navigation No.1, 2.5-6.5 of Chinese yam, 3.0-7.0 of poria and 0.3-1.5 of pericarpium citri reticulatae. A group of effective diet intervention food combination is provided for patients suffering from the recurrent oral ulceration and can be used for diet intervention food development, so that the group of diet food has the functions of promoting the healing of dental ulcer, tonifying spleen, improving unbalance of the intestinal flora, regulating inflammatory cytokine levels in the body and reducing blood fat and has laxative properties, and can effectively solve the problems of insufficiency of the spleen and constipation of patients, prevention of hyperlipidemia, reduction of prevalence rate. The food composite can be prepared into instant rice sticks, instant congees and the like, and is convenient to use, free of medicine side effects, safe to use and good in curative effect.
Owner:THE SECOND AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV
Compounds for treating mitochondrial disease
ActiveUS10815211B2High expressionReduce fragmentationSenses disorderNervous disorderDiseasePharmaceutical Substances
Owner:KHONDRION IP
Traditional Chinese medicine plaster for preventing and treating motion sickness
InactiveCN103638470AGood for anti-motion sicknessEasy to useDigestive systemSheet deliveryMotion sicknessSide effect
The invention relates to a traditional Chinese medicine plaster for preventing and treating motion sickness. The traditional Chinese medicine plaster can effectively solve the problems that the existing medicine is large in side effects and inconvenient to take. The technical scheme is as follows: the traditional Chinese medicine plaster is composed of the following raw material medicines by weight: 8-20 g of patchouli, 3-10 g of lavender, 10-30 g of lily, 8-20 g of cortex albiziae, 3-10 g of magnolia flower, 9-20 g of radix angelicae, 8-20 g of radix curcumae, 3-10 g of flos mume, 8-20 g of fingered citron, 8-20 g of rhizoma galangae and 5-20 g of acorus tatarinowii, the traditional Chinese medicine plaster disclosed by the invention has a good curative effect on motion sickness and is simple to make, low in cost and good in application cost, so that the traditional Chinese medicine plaster is an innovation on medicine for preventing and treating motion sickness.
Owner:HENAN UNIV OF CHINESE MEDICINE
Terbinafine hydrochloride solid dispersoid and tablet thereof
ActiveCN102641252BImprove in vitro dissolutionReduce dosageOrganic active ingredientsAntimycoticsBULK ACTIVE INGREDIENTPharmaceutical Substances
Owner:NANJING CHENGONG PHARM CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com